Rapid multislice imaging of hyperpolarized 13C pyruvate and bicarbonate in the heart.

PubWeight™: 1.80‹?› | Rank: Top 3%

🔗 View Article (PMID 20574989)

Published in Magn Reson Med on November 01, 2010

Authors

Angus Z Lau1, Albert P Chen, Nilesh R Ghugre, Venkat Ramanan, Wilfred W Lam, Kim A Connelly, Graham A Wright, Charles H Cunningham

Author Affiliations

1: Department of Medical Biophysics, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, Ontario, Canada. angus.lau@sri.utoronto.ca

Articles citing this

Metabolic imaging of patients with prostate cancer using hyperpolarized [1-¹³C]pyruvate. Sci Transl Med (2013) 4.23

Hyperpolarized (13)C magnetic resonance reveals early- and late-onset changes to in vivo pyruvate metabolism in the failing heart. Eur J Heart Fail (2012) 1.82

Chemistry and biochemistry of 13C hyperpolarized magnetic resonance using dynamic nuclear polarization. Chem Soc Rev (2013) 1.41

Flux through hepatic pyruvate carboxylase and phosphoenolpyruvate carboxykinase detected by hyperpolarized 13C magnetic resonance. Proc Natl Acad Sci U S A (2011) 1.29

Hyperpolarized magnetic resonance: a novel technique for the in vivo assessment of cardiovascular disease. Circulation (2011) 1.24

Hyperpolarized magnetic resonance as a sensitive detector of metabolic function. Biochemistry (2014) 1.20

Could 13C MRI assist clinical decision-making for patients with heart disease? NMR Biomed (2011) 1.14

Simultaneous investigation of cardiac pyruvate dehydrogenase flux, Krebs cycle metabolism and pH, using hyperpolarized [1,2-(13)C2]pyruvate in vivo. NMR Biomed (2011) 1.11

Clinical implications of cardiac hyperpolarized magnetic resonance imaging. J Cardiovasc Magn Reson (2013) 1.07

Impact of Gd3+ on DNP of [1-13C]pyruvate doped with trityl OX063, BDPA, or 4-oxo-TEMPO. J Phys Chem A (2012) 1.07

Fast volumetric imaging of ethanol metabolism in rat liver with hyperpolarized [1-(13) C]pyruvate. NMR Biomed (2012) 1.03

Strategies for rapid in vivo 1H and hyperpolarized 13C MR spectroscopic imaging. J Magn Reson (2013) 0.98

Multi-band frequency encoding method for metabolic imaging with hyperpolarized [1-(13)C]pyruvate. J Magn Reson (2011) 0.96

Noninvasive identification and assessment of functional brown adipose tissue in rodents using hyperpolarized ¹³C imaging. Int J Obes (Lond) (2013) 0.95

A rapid method for direct detection of metabolic conversion and magnetization exchange with application to hyperpolarized substrates. J Magn Reson (2012) 0.95

A method for simultaneous echo planar imaging of hyperpolarized ¹³C pyruvate and ¹³C lactate. J Magn Reson (2012) 0.93

Frequency-specific SSFP for hyperpolarized ¹³C metabolic imaging at 14.1 T. Magn Reson Imaging (2012) 0.92

Real-time detection of hepatic gluconeogenic and glycogenolytic states using hyperpolarized [2-13C]dihydroxyacetone. J Biol Chem (2014) 0.91

Generating super stimulated-echoes in MRI and their application to hyperpolarized C-13 diffusion metabolic imaging. IEEE Trans Med Imaging (2011) 0.90

In vivo single-shot 13C spectroscopic imaging of hyperpolarized metabolites by spatiotemporal encoding. J Magn Reson (2014) 0.89

Rapid in vivo apparent diffusion coefficient mapping of hyperpolarized (13) C metabolites. Magn Reson Med (2014) 0.87

Dynamic metabolic imaging of hyperpolarized [2-(13) C]pyruvate using spiral chemical shift imaging with alternating spectral band excitation. Magn Reson Med (2013) 0.87

Application of hyperpolarized [1-¹³C]lactate for the in vivo investigation of cardiac metabolism. NMR Biomed (2012) 0.87

Radial spectroscopic MRI of hyperpolarized [1-(13) C] pyruvate at 7 tesla. Magn Reson Med (2013) 0.86

Hyperpolarized 13C Metabolic MRI of the Human Heart: Initial Experience. Circ Res (2016) 0.86

In vivo investigation of cardiac metabolism in the rat using MRS of hyperpolarized [1-13C] and [2-13C]pyruvate. NMR Biomed (2013) 0.83

Robust and high resolution hyperpolarized metabolic imaging of the rat heart at 7 t with 3d spectral-spatial EPI. Magn Reson Med (2015) 0.83

In vivo mouse cardiac hyperpolarized magnetic resonance spectroscopy. J Cardiovasc Magn Reson (2013) 0.83

Assessing Cardiac Metabolism: A Scientific Statement From the American Heart Association. Circ Res (2016) 0.82

Simultaneous assessment of cardiac metabolism and perfusion using copolarized [1-(13) C]pyruvate and (13) C-urea. Magn Reson Med (2016) 0.82

Concentric rings K-space trajectory for hyperpolarized (13) C MR spectroscopic imaging. Magn Reson Med (2014) 0.81

Propionate stimulates pyruvate oxidation in the presence of acetate. Am J Physiol Heart Circ Physiol (2014) 0.80

Multiband spectral-spatial RF excitation for hyperpolarized [2-(13) C]dihydroxyacetone (13) C-MR metabolism studies. Magn Reson Med (2016) 0.80

Application of Good's buffers to pH imaging using hyperpolarized (13)C MRI. Chem Commun (Camb) (2015) 0.78

Imaging Renal Urea Handling in Rats at Millimeter Resolution using Hyperpolarized Magnetic Resonance Relaxometry. Tomography (2016) 0.78

Selective spectroscopic imaging of hyperpolarized pyruvate and its metabolites using a single-echo variable phase advance method in balanced SSFP. Magn Reson Med (2015) 0.77

Parameterization of hyperpolarized (13)C-bicarbonate-dissolution dynamic nuclear polarization. MAGMA (2015) 0.76

Development of a symmetric echo planar imaging framework for clinical translation of rapid dynamic hyperpolarized (13) C imaging. Magn Reson Med (2016) 0.76

Spectrally selective three-dimensional dynamic balanced steady-state free precession for hyperpolarized C-13 metabolic imaging with spectrally selective radiofrequency pulses. Magn Reson Med (2016) 0.76

Chemical shift separation with controlled aliasing for hyperpolarized (13) C metabolic imaging. Magn Reson Med (2014) 0.76

Speeding up dynamic spiral chemical shift imaging with incoherent sampling and low-rank matrix completion. Magn Reson Med (2016) 0.75

Imaging oxygen metabolism with hyperpolarized magnetic resonance: a novel approach for cardiac and renal function assessement. Biosci Rep (2016) 0.75

Metabolite-selective hyperpolarized (13)C imaging using extended chemical shift displacement at 9.4T. Magn Reson Imaging (2015) 0.75

Simultaneous imaging of 13C metabolism and 1H structure: technical considerations and potential applications. NMR Biomed (2015) 0.75

Development of High Resolution 3D Hyperpolarized Carbon-13 MR Molecular Imaging Techniques. Magn Reson Imaging (2017) 0.75

Single shot three-dimensional pulse sequence for hyperpolarized (13) C MRI. Magn Reson Med (2016) 0.75

Mapping of intracellular pH in the in vivo rodent heart using hyperpolarized [1-13C]pyruvate. Magn Reson Med (2016) 0.75

Articles by these authors

Analysis of cancer metabolism by imaging hyperpolarized nuclei: prospects for translation to clinical research. Neoplasia (2011) 5.53

Hyperpolarized 13C lactate, pyruvate, and alanine: noninvasive biomarkers for prostate cancer detection and grading. Cancer Res (2008) 4.79

Metabolic imaging of patients with prostate cancer using hyperpolarized [1-¹³C]pyruvate. Sci Transl Med (2013) 4.23

Hyperpolarized C-13 spectroscopic imaging of the TRAMP mouse at 3T-initial experience. Magn Reson Med (2007) 4.13

Double spin-echo sequence for rapid spectroscopic imaging of hyperpolarized 13C. J Magn Reson (2007) 3.35

The (Pro)renin receptor: site-specific and functional linkage to the vacuolar H+-ATPase in the kidney. Hypertension (2009) 2.47

Compressed sensing for resolution enhancement of hyperpolarized 13C flyback 3D-MRSI. J Magn Reson (2008) 2.39

Design of flyback echo-planar readout gradients for magnetic resonance spectroscopic imaging. Magn Reson Med (2005) 2.33

Intravascular and extravascular microvessel formation in chronic total occlusions a micro-CT imaging study. JACC Cardiovasc Imaging (2010) 2.17

Current perspectives on coronary chronic total occlusions: the Canadian Multicenter Chronic Total Occlusions Registry. J Am Coll Cardiol (2012) 2.11

Flexible real-time magnetic resonance imaging framework. Conf Proc IEEE Eng Med Biol Soc (2004) 2.11

Kinetic modeling of hyperpolarized 13C1-pyruvate metabolism in normal rats and TRAMP mice. J Magn Reson (2009) 2.05

Rapid high-resolution T(1) mapping by variable flip angles: accurate and precise measurements in the presence of radiofrequency field inhomogeneity. Magn Reson Med (2006) 1.93

Multi-compound polarization by DNP allows simultaneous assessment of multiple enzymatic activities in vivo. J Magn Reson (2010) 1.84

DWI of the spinal cord with reduced FOV single-shot EPI. Magn Reson Med (2008) 1.82

Hyperpolarized (13)C magnetic resonance reveals early- and late-onset changes to in vivo pyruvate metabolism in the failing heart. Eur J Heart Fail (2012) 1.82

Investigation of tumor hyperpolarized [1-13C]-pyruvate dynamics using time-resolved multiband RF excitation echo-planar MRSI. Magn Reson Med (2010) 1.64

Hybrid intravascular ultrasound and optical coherence tomography catheter for imaging of coronary atherosclerosis. Catheter Cardiovasc Interv (2012) 1.64

Pulse sequence for dynamic volumetric imaging of hyperpolarized metabolic products. J Magn Reson (2008) 1.64

Quantitative apparent diffusion coefficients and T2 relaxation times in characterizing contrast enhancing brain tumors and regions of peritumoral edema. J Magn Reson Imaging (2005) 1.63

Multiband excitation pulses for hyperpolarized 13C dynamic chemical-shift imaging. J Magn Reson (2008) 1.62

In vivo carbon-13 dynamic MRS and MRSI of normal and fasted rat liver with hyperpolarized 13C-pyruvate. Mol Imaging Biol (2009) 1.61

Variable-rate selective excitation for rapid MRI sequences. Magn Reson Med (2004) 1.57

n-3 Polyunsaturated fatty acids alter expression of fibrotic and hypertrophic genes in a dog model of atrial cardiomyopathy. Heart Rhythm (2009) 1.54

Relationship between initial treatment strategy and quality of life in patients with coronary chronic total occlusions. EuroIntervention (2014) 1.41

Hyperpolarized [2-13C]-fructose: a hemiketal DNP substrate for in vivo metabolic imaging. J Am Chem Soc (2009) 1.38

Time-resolved MR angiography with limited projections. Magn Reson Med (2007) 1.28

Real-time cardiac MRI at 3 tesla. Magn Reson Med (2004) 1.28

eNOS deficiency predisposes podocytes to injury in diabetes. J Am Soc Nephrol (2012) 1.26

Single breath-hold whole-heart MRA using variable-density spirals at 3T. Magn Reson Med (2006) 1.23

A human ferritin iron oxide nano-composite magnetic resonance contrast agent. Magn Reson Med (2008) 1.23

Expression, localization, and function of the thioredoxin system in diabetic nephropathy. J Am Soc Nephrol (2009) 1.22

Analysis of hyperpolarized dynamic 13C lactate imaging in a transgenic mouse model of prostate cancer. Magn Reson Imaging (2009) 1.21

Dynamic contrast-enhanced MRI and MR diffusion imaging to distinguish between glandular and stromal prostatic tissues. Magn Reson Imaging (2008) 1.21

Electrostatic forward-viewing scanning probe for Doppler optical coherence tomography using a dissipative polymer catheter. Opt Lett (2008) 1.20

Optimized spiral imaging for measurement of myocardial T2 relaxation. Magn Reson Med (2003) 1.17

Intracranial venous system: gadolinium-enhanced three-dimensional MR venography with auto-triggered elliptic centric-ordered sequence--initial experience. Radiology (2003) 1.17

Sequence design for magnetic resonance spectroscopic imaging of prostate cancer at 3 T. Magn Reson Med (2005) 1.17

Long-term administration of the histone deacetylase inhibitor vorinostat attenuates renal injury in experimental diabetes through an endothelial nitric oxide synthase-dependent mechanism. Am J Pathol (2011) 1.17

Histone deacetylase inhibition attenuates diabetes-associated kidney growth: potential role for epigenetic modification of the epidermal growth factor receptor. Kidney Int (2011) 1.17

Generation of hyperpolarized substrates by secondary labeling with [1,1-13C] acetic anhydride. Proc Natl Acad Sci U S A (2009) 1.15

Implementation of 3 T lactate-edited 3D 1H MR spectroscopic imaging with flyback echo-planar readout for gliomas patients. Ann Biomed Eng (2010) 1.14

Practical medical applications of quantitative MR relaxometry. J Magn Reson Imaging (2012) 1.14

Characterizing myocardial edema and hemorrhage using quantitative T2 and T2* mapping at multiple time intervals post ST-segment elevation myocardial infarction. Circ Cardiovasc Imaging (2012) 1.13

Culture-modified bone marrow cells attenuate cardiac and renal injury in a chronic kidney disease rat model via a novel antifibrotic mechanism. PLoS One (2010) 1.13

Quantitative tracking of edema, hemorrhage, and microvascular obstruction in subacute myocardial infarction in a porcine model by MRI. Magn Reson Med (2011) 1.13

Oxygen-sensitive contrast in blood for steady-state free precession imaging. Magn Reson Med (2005) 1.13

Hyperpolarized 3He ventilation defects and apparent diffusion coefficients in chronic obstructive pulmonary disease: preliminary results at 3.0 Tesla. Invest Radiol (2007) 1.12

Simultaneous investigation of cardiac pyruvate dehydrogenase flux, Krebs cycle metabolism and pH, using hyperpolarized [1,2-(13)C2]pyruvate in vivo. NMR Biomed (2011) 1.11

Spinal dural arteriovenous fistula localization with a technique of first-pass gadolinium-enhanced MR angiography: initial experience. Radiology (2002) 1.09

Nonrigid motion correction in 3D using autofocusing with localized linear translations. Magn Reson Med (2012) 1.09

Affine and polynomial mutual information coregistration for artifact elimination in diffusion tensor imaging of newborns. Magn Reson Imaging (2004) 1.08

Temporal stability of adaptive 3D radial MRI using multidimensional golden means. Magn Reson Med (2009) 1.08

Innovations in imaging for chronic total occlusions: a glimpse into the future of angiography's blind-spot. Eur Heart J (2008) 1.08

Spectral-spatial excitation for rapid imaging of DNP compounds. NMR Biomed (2011) 1.07

Considerations in applying 3D PRESS H-1 brain MRSI with an eight-channel phased-array coil at 3 T. Magn Reson Imaging (2006) 1.06

High-resolution 3D MR spectroscopic imaging of the prostate at 3 T with the MLEV-PRESS sequence. Magn Reson Imaging (2006) 1.04

Targeted inhibition of activin receptor-like kinase 5 signaling attenuates cardiac dysfunction following myocardial infarction. Am J Physiol Heart Circ Physiol (2010) 1.03

α11 integrin stimulates myofibroblast differentiation in diabetic cardiomyopathy. Cardiovasc Res (2012) 1.02

Detecting microcirculatory changes in blood oxygen state with steady-state free precession imaging. Magn Reson Med (2006) 1.01

Design of symmetric-sweep spectral-spatial RF pulses for spectral editing. Magn Reson Med (2004) 1.00

High-speed 3T MR spectroscopic imaging of prostate with flyback echo-planar encoding. J Magn Reson Imaging (2007) 0.98

Spin-history artifact during functional MRI: potential for adaptive correction. Med Phys (2011) 0.98

High-order multiband encoding in the heart. Magn Reson Med (2002) 0.95

Fluorescent microangiography is a novel and widely applicable technique for delineating the renal microvasculature. PLoS One (2011) 0.94

Early-outgrowth bone marrow cells attenuate renal injury and dysfunction via an antioxidant effect in a mouse model of type 2 diabetes. Diabetes (2012) 0.94

(1)H spectroscopic imaging of human brain at 3 Tesla: comparison of fast three-dimensional magnetic resonance spectroscopic imaging techniques. J Magn Reson Imaging (2009) 0.94

Cardiac phase-resolved blood oxygen-sensitive steady-state free precession MRI for evaluating the functional significance of coronary artery stenosis. Invest Radiol (2007) 0.94

Integrated Bloch-Siegert B₁ mapping and multislice imaging of hyperpolarized ¹³C pyruvate and bicarbonate in the heart. Magn Reson Med (2011) 0.93

Comparative assessment of 2-dimensional echocardiography vs cardiac magnetic resonance imaging in measuring left ventricular mass in patients with and without end-stage renal disease. Can J Cardiol (2012) 0.93

Quantification of fibrosis in infarcted swine hearts by ex vivo late gadolinium-enhancement and diffusion-weighted MRI methods. Phys Med Biol (2013) 0.93

A calibration-based approach to real-time in vivo monitoring of pyruvate C₁ and C₂ polarization using the JCC spectral asymmetry. NMR Biomed (2013) 0.92

Ultrasound-guided identification of cardiac imaging windows. Med Phys (2012) 0.92

Design of spectral-spatial outer volume suppression RF pulses for tissue specific metabolic characterization with hyperpolarized 13C pyruvate. J Magn Reson (2009) 0.92

In vivo MRI measurement of blood oxygen saturation in children with congenital heart disease. Pediatr Radiol (2004) 0.92

Variable-density adaptive imaging for high-resolution coronary artery MRI. Magn Reson Med (2002) 0.91

Correspondence between simple 3-D MRI-based computer models and in-vivo EP measurements in swine with chronic infarctions. IEEE Trans Biomed Eng (2011) 0.91

The effect of altering heart rate on ventricular function in patients with heart failure treated with beta-blockers. Am Heart J (2006) 0.91

Potential clinical impact of cardiovascular magnetic resonance assessment of ejection fraction on eligibility for cardioverter defibrillator implantation. J Cardiovasc Magn Reson (2012) 0.90

MRI-based blood oxygen saturation measurements in infants and children with congenital heart disease. Pediatr Radiol (2002) 0.89

Three-dimensional J-resolved H-1 magnetic resonance spectroscopic imaging of volunteers and patients with brain tumors at 3T. Magn Reson Med (2007) 0.89

Temporal changes in the management and outcome of Canadian diabetic patients hospitalized for non-ST-elevation acute coronary syndromes. Am Heart J (2011) 0.89